Browsing: Gastrointestinal

The outcomes of the Chinese phase 3 NOTABLE trial that demonstrated across 92 patients with KRAS-wildtype unresectable and/or metastatic pancreatic…

The sequencing of chemotherapy, radiation, and surgery has been forefront in recent trials for locally advanced rectal cancer. But what…

The phase 2 DYNAMIC trial demonstrates that patients with resected stage II colon cancer randomized to post-surgery circulating tumor DNA-determined…

This case report describes an exciting (although n=1) response to T-cell receptor gene therapy in a patient with refractory, metastatic…

Top Line: Perioperative FLOT is cemented as the current standard of care for locally-advanced gastric cancer, but is the post-op…

With the incidence of colorectal cancer (CRC) increasing among people under 50, the USPSTF recently lowered the age to initiate…

Top Line: Local treatment of the primary tumor site in the setting of distant disease has known advantages for cancers…

Top Line: Who needs neoadjuvant therapy for rectal cancer? The Study: With total neoadjuvant therapy being all the rage, this…

Top Line: After decades with no major headway, the treatment of locally-advanced rectal cancer has seen some paradigm shifts over…